News from the FDA/CDC
News from the FDA/CDC
Drugs identified after suicide deaths
Tests for antidepressants and alcohol were the most likely to be positive.
News from the FDA/CDC
Women filling more ADHD prescriptions
Increase in possible medication exposure during pregnancy “is of public health concern.”
News from the FDA/CDC
Office visits have a chronic problem
Adult visits are more often for long term problems, but pediatric visits tend to be for acute conditions.
News from the FDA/CDC
Developmental disabilities up significantly since 2014
Autism spectrum disorder was almost three times as prevalent in boys as in girls in 2014-2016.
FDA/CDC
New buprenorphine formulation approved for medication-assisted treatment
Patients who are currently taking other buprenorphine formulations can be transitioned.
FDA/CDC
FDA clears first-ever neurostimulation device for opioid withdrawal symptoms
In one study, almost 90% of patients transitioned to medication-assisted treatment after 5 days of using the device.
Latest News
Adherence boon, or Big Brother loom?
Take our poll on the first drug approved in the United States with a digital ingestion tracking system.
FDA/CDC
FDA approves cariprazine for schizophrenia maintenance treatment
Approval is based on results of a 72-week double-blind, randomized study of three daily doses of the antipsychotic, compared with placebo.
From the Journals
Public health hazard: Bring your flu to work day
Many physicians and pharmacists report working while having influenza-like illness.
FDA/CDC
FDA panels support two NDAs for buprenorphine subcutaneous injections
The panelists agree that subcutaneous formulations might help step the opioid epidemic.
News from the FDA/CDC
Fentanyl analogues an increasing factor in opioid deaths
Almost 30% of opioid overdose deaths in Maine involved carfentanil or similar products.